Remove why-life-sciences-sales-compensation-plans-must-change-to-address-covid-19
article thumbnail

Why Life Sciences Sales Compensation Plans Must Change to Address COVID-19

The Marketing Advantage

April 7, 2020 With social distancing during COVID-19 leaving pharma, biotech and medical device sales representatives at home rather than in the field, what does this mean for the sales incentive compensation plans they are being compensated against? Will different parts of the country recover sooner?

Sales 52